Search research articles
Contact Us
Filters
Showing results (301-310 of 377) with videos related to
Page
of 38
Sort By:
Cancer Immunology, Immunotherapy : CII
|
September 5, 2023
Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC)
Emanuele Vita, Alessio Stefani, Geny Piro, et al.
Breast (Edinburgh, Scotland)
|
June 20, 2017
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation
Luisa Carbognin, Isabella Sperduti, Alessandra Fabi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 26, 2017
Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective study
Elisa Gobbini, Domenico Galetta, Marcello Tiseo, et al.
Clinical Lung Cancer
|
July 30, 2025
The Italian Mauris Phase IIIb Trial of Atezolizumab Plus Carboplatin and Etoposide for Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer: 3-Year End-of-Study Results
Floriana Morgillo, Ester Del Signore, Emilio Bria, et al.
Journal for Immunotherapy of Cancer
|
November 28, 2023
Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer-Immun-HER trial (GOIRC-01-2016)
Benedetta Pellegrino, Chiara Tommasi, Olga Serra, et al.
Journal of Translational Medicine
|
November 23, 2023
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer
Antonio Agostini, Ilaria Guerriero, Geny Piro, et al.
Therapeutic Advances in Medical Oncology
|
October 2, 2024
Efficacy of carboplatin-etoposide rechallenge after first-line chemo-immunotherapy in ES-SCLC: an international multicentric analysis
Igor Gomez-Randulfe, Sofía Silva Díaz, Carles Escriu, et al.
International Journal of Molecular Sciences
|
July 29, 2025
HER2-Driven Breast Cancer: Role of the Chaperonin HSP90 in Modulating Response to Trastuzumab-Based Therapeutic Combinations
Italia Falcone, Elena Giontella, Stefano Giuliani, et al.
Acta Oncologica (Stockholm, Sweden)
|
May 19, 2025
Simultaneous integrated boost intensity-modulated radiotherapy for treatment of bone metastases: analysis of a breast cancer cohort
Fabio Marazzi, Valeria Masiello, Alessandra Fabi, et al.
Plos One
|
November 14, 2019
Management of locally advanced non-small cell lung cancer in the modern era: A national Italian survey on diagnosis, treatment and multidisciplinary approach
Alessio Bruni, Niccolò Giaj-Levra, Patrizia Ciammella, et al.
Page
of 38
Search research articles
Search
Showing results (301-310 of 377) with videos related to
Sort By:
Page
of 38
Cancer Immunology, Immunotherapy : CII
|
September 5, 2023
Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC)
Emanuele Vita, Alessio Stefani, Geny Piro, et al.
Breast (Edinburgh, Scotland)
|
June 20, 2017
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation
Luisa Carbognin, Isabella Sperduti, Alessandra Fabi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 26, 2017
Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective study
Elisa Gobbini, Domenico Galetta, Marcello Tiseo, et al.
Clinical Lung Cancer
|
July 30, 2025
The Italian Mauris Phase IIIb Trial of Atezolizumab Plus Carboplatin and Etoposide for Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer: 3-Year End-of-Study Results
Floriana Morgillo, Ester Del Signore, Emilio Bria, et al.
Journal for Immunotherapy of Cancer
|
November 28, 2023
Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer-Immun-HER trial (GOIRC-01-2016)
Benedetta Pellegrino, Chiara Tommasi, Olga Serra, et al.
Journal of Translational Medicine
|
November 23, 2023
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer
Antonio Agostini, Ilaria Guerriero, Geny Piro, et al.
Therapeutic Advances in Medical Oncology
|
October 2, 2024
Efficacy of carboplatin-etoposide rechallenge after first-line chemo-immunotherapy in ES-SCLC: an international multicentric analysis
Igor Gomez-Randulfe, Sofía Silva Díaz, Carles Escriu, et al.
International Journal of Molecular Sciences
|
July 29, 2025
HER2-Driven Breast Cancer: Role of the Chaperonin HSP90 in Modulating Response to Trastuzumab-Based Therapeutic Combinations
Italia Falcone, Elena Giontella, Stefano Giuliani, et al.
Acta Oncologica (Stockholm, Sweden)
|
May 19, 2025
Simultaneous integrated boost intensity-modulated radiotherapy for treatment of bone metastases: analysis of a breast cancer cohort
Fabio Marazzi, Valeria Masiello, Alessandra Fabi, et al.
Plos One
|
November 14, 2019
Management of locally advanced non-small cell lung cancer in the modern era: A national Italian survey on diagnosis, treatment and multidisciplinary approach
Alessio Bruni, Niccolò Giaj-Levra, Patrizia Ciammella, et al.
Page
of 38